Vector Biolabs

Philadelphia, United States Founded: 2004 • Age: 22 yrs
Offers custom gene delivery solutions through AAV and Adenovirus for scientific research.

About Vector Biolabs

Vector Biolabs is a Healthcare company based in Philadelphia (United States) founded in 2004. It offers custom gene delivery solutions through AAV and Adenovirus for scientific research. It operates on a B2B and Direct Sales model. Vector Biolabs offers products and services including Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products. Its focus areas include Life Sciences, Biotechnology, Research Tools and Gene Expression Products. Its legal entity is Vector Biosystems, Inc. Similar companies include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed similar companies have raised funding.

Company details

Vector Biolabs specializes in providing custom services for recombinant AAV and Adenovirus, including vector design, cloning, packaging, and purification. They offer an extensive catalog of viral products for gene expression and therapy needs. Based in Malvern, PA, USA, they serve researchers and institutions requiring high-quality gene delivery tools for various applications.

  • Headquarters Philadelphia, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website vectorbiolabs.com
  • Legal Name Vector Biosystems, Inc.

Products & Services of Vector Biolabs

Vector Biolabs offers a comprehensive portfolio of products and services, including Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products.

Custom AAV Production
Gene Delivery Service

Service for designing and producing AAV vectors for research applications.

Adenovirus Services
Viral Vector Service

Custom services for adenovirus vector production and amplification.

AAV Products
Gene Therapy Tools

Pre-made AAV products for gene expression and research needs.

Adenovirus Products
Viral Vectors

Ready-to-use adenovirus for scientific and therapeutic applications.

People of Vector Biolabs

1 people are tracked at Vector Biolabs (1 in leadership).

NameRoleGroup
Jeffrey Edwards
CEOLeadership
Premium access

Complete people profiles for Vector Biolabs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Similar companies to Vector Biolabs

Vector Biolabs has 3 listed similar companies in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
Premium access

Detailed similar companies of Vector Biolabs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Vector Biolabs

Websites that share an audience with Vector Biolabs (vectorbiolabs.com).

Similar websites

Websites whose visitors overlap most with Vector Biolabs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
amsbio.com
93%
59.3K#613,920View details
vectorbuilder.com
90%
127.2KView details
genecopoeia.com
75%
17.2K#1,512,108View details
vectorlabs.com
63%
65.9K#500,436View details

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Vector Biolabs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vector Biolabs

Vector Biolabs was founded in 2004.

Vector Biolabs is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Vector Biolabs specializes in providing custom services for recombinant AAV and Adenovirus, including vector design, cloning, packaging, and purification. They offer an extensive catalog of viral products for gene expression and therapy needs. Based in Malvern, PA, USA, they serve researchers and institutions requiring high-quality gene delivery tools for various applications.

Vector Biolabs's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.

Vector Biolabs offers Custom AAV Production, Adenovirus Services, AAV Products, and Adenovirus Products.

Vector Biolabs operates through Vector Biosystems, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available